세계의 외부 카테터 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 재료별, 성별, 최종 용도별, 지역별, 부문 예측(2025-2033년)

External Catheters Market Summary

The global external catheters market size was estimated at USD 2.82 billion in 2024 and is projected to reach USD 4.95 billion by 2033, growing at a CAGR of 6.49% from 2025 to 2033. This growth is driven by the rising geriatric population and increasing prevalence of urological disorders such as urinary incontinence and prostate-related conditions.

Moreover, the growing adoption of home healthcare and technological advancements in catheter design and materials are further boosting market demand. The increasing prevalence of urological disorders is a key factor driving growth in the external catheters market. In 2025, OU Health reported that nearly 80 million women in the U.S. experience urinary incontinence (UI), affecting 1 in 2 women. Additionally, data from City of Hope in November 2024 revealed that 11% to 34% of older men experience UI, with 2% to 11% reporting daily occurrences. This substantial burden highlights a growing need for non-invasive urinary management solutions, supporting the continued expansion of the external catheters segment in the coming years.

In addition to the rising burden of urinary incontinence, the increasing prevalence of cancers-such as bladder cancer, prostate cancer, and ovarian cancer-is further contributing to the growing demand for external catheters. Patients undergoing treatment for these cancers often experience urinary complications or require temporary catheterization due to surgery. External catheters, also known as condom catheters, offer a less invasive and more comfortable solution for managing urinary output in such cases, particularly for patients with limited mobility or sensitivity post-treatment. As these cancers continue to rise globally, the need for reliable, non-invasive urinary management options like external catheters is expected to increase, driving sustained market growth.

The increasing preference for external catheters or condom catheters, particularly among female patients, is anticipated to create significant growth opportunities in the market. Several companies in the industry have already reported encouraging feedback, reinforcing the market potential.

Furthermore, the availability of reimbursement for external catheters for both male and female patients is expected to support market adoption significantly. Reimbursement policies reduce the financial burden on patients and healthcare providers, encouraging wider usage and accessibility. This support is particularly crucial in long-term care and chronic condition management settings.

In addition, companies are receiving reimbursement approvals for external catheters. For instance, in April 2023, Ur24 Technology, Inc., a privately held medical device company, achieved a significant milestone by securing Medicare reimbursement approval for its TrueClr external catheter system. Such reimbursement approvals are anticipated to support the market expansion in the coming years.

Global External Catheters Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global external catheters market report based on product, material, gender, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Self-Adhesive
• Non-adhesive
• Material Outlook (Revenue, USD Million, 2021 - 2033)
• Silicone
• Latex
• Others
• Gender Outlook (Revenue, USD Million, 2021 - 2033)
• Male
• Female
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Home Healthcare
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. Material
  • 1.1.3. Gender
  • 1.1.4. End use
  • 1.1.5. Regional scope
  • 1.1.6. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. External Catheters Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing burden of urological disorders
    • 3.2.1.2. Growing awareness about urinary incontinence management
    • 3.2.1.3. Introduction of innovative and advanced external catheters
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Recalls of external catheters
  • 3.2.3. Market opportunity analysis
    • 3.2.3.1. Growing number of clinical trials
    • 3.2.3.2. Growth potential in emerging economies in the external catheters market
    • 3.2.3.3. Rising preferences for female external catheters
    • 3.2.3.4. Patent approvals and strategic partnerships boost market visibility and expansion
  • 3.2.4. Market challenge analysis
    • 3.2.4.1. Potential complications and risks associated with external catheters
• 3.3. External Catheters Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. External Catheters Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global External Catheters Market Product Movement Analysis
• 4.3. Global External Catheters Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 4.4. Self-Adhesive
  • 4.4.1. Self-adhesive market estimates and forecasts for 2021 to 2033 (USD Million)
• 4.5. Non-Adhesive
  • 4.5.1. Non-adhesive market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 5. External Catheters Market: Material Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global External Catheters Market Material Movement Analysis
• 5.3. Global External Catheters Market Size & Trend Analysis, by Material, 2021 to 2033 (USD Million)
• 5.4. Silicone
  • 5.4.1. Silicone market estimates and forecasts for 2021 to 2033 (USD Million)
• 5.5. Latex
  • 5.5.1. Latex market estimates and forecasts for 2021 to 2033 (USD Million)
• 5.6. Others
  • 5.6.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 6. External Catheters Market: Gender Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global External Catheters Market Gender Movement Analysis
• 6.3. Global External Catheters Market Size & Trend Analysis, by Gender, 2021 to 2033 (USD Million)
• 6.4. Male
  • 6.4.1. Male market estimates and forecasts for 2021 to 2033 (USD Million)
• 6.5. Female
  • 6.5.1. Female market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 7. External Catheters Devices: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global External Catheters Market End Use Movement Analysis
• 7.3. Global External Catheters Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 7.4. Hospitals
  • 7.4.1. Hospitals market estimates and forecasts for 2021 to 2033 (USD Million)
• 7.5. Home Healthcare
  • 7.5.1. Home healthcare market estimates and forecasts for 2021 to 2033 (USD Million)
• 7.6. Others
  • 7.6.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 8. External Catheters Market: Regional Estimates & Trend Analysis

• 8.1. Regional Dashboard
• 8.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
• 8.3. North America
  • 8.3.1. Market estimates and forecast, 2021 to 2033 ( USD Million)
  • 8.3.2. U.S.
    • 8.3.2.1. Key country dynamics
    • 8.3.2.2. Competitive scenario
    • 8.3.2.3. Regulatory framework
    • 8.3.2.4. Reimbursement scenario
    • 8.3.2.5. U.S. market estimates and forecasts, 2021 - 2033
  • 8.3.3. Canada
    • 8.3.3.1. Key country dynamics
    • 8.3.3.2. Competitive scenario
    • 8.3.3.3. Regulatory framework
    • 8.3.3.4. Reimbursement scenario
    • 8.3.3.5. Canada market estimates and forecasts, 2021 - 2033
  • 8.3.4. Mexico
    • 8.3.4.1. Key country dynamics
    • 8.3.4.2. Competitive scenario
    • 8.3.4.3. Regulatory framework
    • 8.3.4.4. Reimbursement scenario
    • 8.3.4.5. Mexico market estimates and forecasts, 2021 - 2033
• 8.4. Europe
  • 8.4.1. UK
    • 8.4.1.1. Key country dynamics
    • 8.4.1.2. Competitive scenario
    • 8.4.1.3. Regulatory framework
    • 8.4.1.4. Reimbursement scenario
    • 8.4.1.5. UK market estimates and forecasts, 2021 - 2033
  • 8.4.2. Germany
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Competitive scenario
    • 8.4.2.3. Regulatory framework
    • 8.4.2.4. Reimbursement scenario
    • 8.4.2.5. Germany market estimates and forecasts, 2021 - 2033
  • 8.4.3. France
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Competitive scenario
    • 8.4.3.3. Regulatory framework
    • 8.4.3.4. Reimbursement scenario
    • 8.4.3.5. France market estimates and forecasts, 2021 - 2033
  • 8.4.4. Italy
    • 8.4.4.1. Key country dynamics
    • 8.4.4.2. Competitive scenario
    • 8.4.4.3. Regulatory framework
    • 8.4.4.4. Reimbursement scenario
    • 8.4.4.5. Italy market estimates and forecasts, 2021 - 2033
  • 8.4.5. Spain
    • 8.4.5.1. Key country dynamics
    • 8.4.5.2. Competitive scenario
    • 8.4.5.3. Regulatory framework
    • 8.4.5.4. Reimbursement scenario
    • 8.4.5.5. Spain market estimates and forecasts, 2021 - 2033
  • 8.4.6. Denmark
    • 8.4.6.1. Key country dynamics
    • 8.4.6.2. Competitive scenario
    • 8.4.6.3. Regulatory framework
    • 8.4.6.4. Reimbursement scenario
    • 8.4.6.5. Denmark market estimates and forecasts, 2021 - 2033
  • 8.4.7. Sweden
    • 8.4.7.1. Key country dynamics
    • 8.4.7.2. Competitive scenario
    • 8.4.7.3. Regulatory framework
    • 8.4.7.4. Reimbursement scenario
    • 8.4.7.5. Sweden market estimates and forecasts, 2021 - 2033
  • 8.4.8. Norway
    • 8.4.8.1. Key country dynamics
    • 8.4.8.2. Competitive scenario
    • 8.4.8.3. Regulatory framework
    • 8.4.8.4. Reimbursement scenario
    • 8.4.8.5. Norway market estimates and forecasts, 2021 - 2033
• 8.5. Asia Pacific
  • 8.5.1. Japan
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Competitive scenario
    • 8.5.1.3. Regulatory framework
    • 8.5.1.4. Reimbursement scenario
    • 8.5.1.5. Japan market estimates and forecasts, 2021 - 2033
  • 8.5.2. India
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Competitive scenario
    • 8.5.2.3. Regulatory framework
    • 8.5.2.4. Reimbursement scenario
    • 8.5.2.5. India market estimates and forecasts, 2021 - 2033
  • 8.5.3. China
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Competitive scenario
    • 8.5.3.3. Regulatory framework
    • 8.5.3.4. Reimbursement scenario
    • 8.5.3.5. China market estimates and forecasts, 2021 - 2033
  • 8.5.4. South Korea
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Competitive scenario
    • 8.5.4.3. Regulatory framework
    • 8.5.4.4. Reimbursement scenario
    • 8.5.4.5. South Korea market estimates and forecasts, 2021 - 2033
  • 8.5.5. Australia
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Competitive scenario
    • 8.5.5.3. Regulatory framework
    • 8.5.5.4. Reimbursement scenario
    • 8.5.5.5. Australia market estimates and forecasts, 2021 - 2033
  • 8.5.6. Thailand
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Competitive scenario
    • 8.5.6.3. Regulatory framework
    • 8.5.6.4. Reimbursement scenario
    • 8.5.6.5. Thailand market estimates and forecasts, 2021 - 2033
• 8.6. Latin America
  • 8.6.1. Brazil
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Competitive scenario
    • 8.6.1.3. Regulatory framework
    • 8.6.1.4. Reimbursement scenario
    • 8.6.1.5. Brazil market estimates and forecasts, 2021 - 2033
  • 8.6.2. Argentina
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Competitive scenario
    • 8.6.2.3. Regulatory framework
    • 8.6.2.4. Reimbursement scenario
    • 8.6.2.5. Argentina market estimates and forecasts, 2021 - 2033
• 8.7. MEA
  • 8.7.1. South Africa
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Competitive scenario
    • 8.7.1.3. Regulatory framework
    • 8.7.1.4. Reimbursement scenario
    • 8.7.1.5. South Africa market estimates and forecasts, 2021 - 2033
  • 8.7.2. Saudi Arabia
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Competitive scenario
    • 8.7.2.3. Regulatory framework
    • 8.7.2.4. Reimbursement scenario
    • 8.7.2.5. Saudi Arabia market estimates and forecasts, 2021 - 2033
  • 8.7.3. UAE
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Competitive scenario
    • 8.7.3.3. Regulatory framework
    • 8.7.3.4. Reimbursement scenario
    • 8.7.3.5. UAE market estimates and forecasts, 2021 - 2033
  • 8.7.4. Kuwait
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Competitive scenario
    • 8.7.4.3. Regulatory framework
    • 8.7.4.4. Reimbursement scenario
    • 8.7.4.5. Kuwait market estimates and forecasts, 2021 - 2033

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Market Participants
• 9.2. Company/Competition Categorization
  • 9.2.1. Innovators
• 9.3. Vendor Landscape
  • 9.3.1. List of key distributors and channel partners
  • 9.3.2. Key customers
  • 9.3.3. Global Key company market share analysis, 2024
  • 9.3.4. Stryker
    • 9.3.4.1. Company overview
    • 9.3.4.2. Financial performance
    • 9.3.4.3. Product benchmarking
    • 9.3.4.4. Strategic initiatives
  • 9.3.5. BD
    • 9.3.5.1. Company overview
    • 9.3.5.2. Financial performance
    • 9.3.5.3. Product benchmarking
    • 9.3.5.4. Strategic initiatives
  • 9.3.6. Consure Medical
    • 9.3.6.1. Company overview
    • 9.3.6.2. Financial performance
    • 9.3.6.3. Product benchmarking
    • 9.3.6.4. Strategic initiatives
  • 9.3.7. Bravida Medical
    • 9.3.7.1. Company overview
    • 9.3.7.2. Financial performance
    • 9.3.7.3. Product benchmarking
    • 9.3.7.4. Strategic initiatives
  • 9.3.8. TillaCare Ltd
    • 9.3.8.1. Company overview
    • 9.3.8.2. Financial performance
    • 9.3.8.3. Product benchmarking
    • 9.3.8.4. Strategic initiatives
  • 9.3.9. Coloplast Corp
    • 9.3.9.1. Company overview
    • 9.3.9.2. Financial performance
    • 9.3.9.3. Product benchmarking
    • 9.3.9.4. Strategic initiatives
  • 9.3.10. Hollister Incorporated
    • 9.3.10.1. Company overview
    • 9.3.10.2. Financial performance
    • 9.3.10.3. Product benchmarking
    • 9.3.10.4. Strategic initiatives
  • 9.3.11. Ur24Technology, Inc.
    • 9.3.11.1. Company overview
    • 9.3.11.2. Financial performance
    • 9.3.11.3. Product benchmarking
    • 9.3.11.4. Strategic initiatives
  • 9.3.12. Cardinal Health
    • 9.3.12.1. Company overview
    • 9.3.12.2. Financial performance
    • 9.3.12.3. Product benchmarking
    • 9.3.12.4. Strategic initiatives
  • 9.3.13. Boehringer Laboratories, LLC
    • 9.3.13.1. Company overview
    • 9.3.13.2. Financial performance
    • 9.3.13.3. Product benchmarking
    • 9.3.13.4. Strategic initiatives
  • 9.3.14. Medline Industries, LP.
    • 9.3.14.1. Company overview
    • 9.3.14.2. Financial performance
    • 9.3.14.3. Product benchmarking
    • 9.3.14.4. Strategic initiatives
  • 9.3.15. B. Braun SE
    • 9.3.15.1. Company overview
    • 9.3.15.2. Financial performance
    • 9.3.15.3. Product benchmarking
    • 9.3.15.4. Strategic initiatives
  • 9.3.16. Ribbel International Limited
    • 9.3.16.1. Company overview
    • 9.3.16.2. Financial performance
    • 9.3.16.3. Product benchmarking
    • 9.3.16.4. Strategic initiatives
  • 9.3.17. Sterimed Group.
    • 9.3.17.1. Company overview
    • 9.3.17.2. Financial performance
    • 9.3.17.3. Product benchmarking
    • 9.3.17.4. Strategic initiatives
  • 9.3.18. Apothecaries Sundries Mfg. Pvt. Ltd.
    • 9.3.18.1. Company overview
    • 9.3.18.2. Financial performance
    • 9.3.18.3. Product benchmarking
    • 9.3.18.4. Strategic initiatives
  • 9.3.19. Medilivescare Manufacturing Pvt. Ltd.
    • 9.3.19.1. Company overview
    • 9.3.19.2. Financial performance
    • 9.3.19.3. Product benchmarking
    • 9.3.19.4. Strategic initiatives
  • 9.3.20. Hangzhou Rollmed Co., Ltd.
    • 9.3.20.1. Company overview
    • 9.3.20.2. Financial performance
    • 9.3.20.3. Product benchmarking
    • 9.3.20.4. Strategic initiatives
  • 9.3.21. Ningbo GreatCare Trading Co., Ltd.
    • 9.3.21.1. Company overview
    • 9.3.21.2. Financial performance
    • 9.3.21.3. Product benchmarking
    • 9.3.21.4. Strategic initiatives
• 9.4. Heat Map Analysis/ Company Market Position Analysis
• 9.5. Estimated Company Market Share Analysis, 2024
• 9.6. List of Other Key Market Players